ARQT - Arcutis Biotherapeutics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ARQT is currently covered by 6 analysts with an average price target of $45.76. This is a potential upside of $15.88 (53.15%) from yesterday's end of day stock price of $29.88.

Arcutis Biotherapeutics 's activity chart (see below) currently has 99 price targets and 89 ratings on display. The stock rating distribution of ARQT is 88.24% BUY and 11.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 39.15% with an average time for these price targets to be met of 98.87 days.

Highest price target for ARQT is $37, Lowest price target is $15, average price target is $21.6.

Most recent stock forecast was given by UY EAR from MIZUHO on 28-Nov-2025. First documented stock forecast 25-Feb-2020.

Currently out of the existing stock ratings of ARQT, 15 are a BUY (88.24%), 2 are a HOLD (11.76%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 03-Jan-2024

$37

$8 (27.59%)

$21

1 months 11 days ago
(28-Nov-2025)

7/19 (36.84%)

$6.04 (19.51%)

269

Buy

Since 07-Sep-2022

$22

$-7 (-24.14%)

$20

5 months 1 days ago
(07-Aug-2025)

19/21 (90.48%)

$7.88 (55.81%)

443

Buy

Since 30-Dec-2024

$19

$-10 (-34.48%)

$19

9 months 5 days ago
(03-Apr-2025)

4/4 (100%)

$2.84 (17.57%)

234

Buy

Since 25-Feb-2020

9 months 5 days ago
(03-Apr-2025)

1/1 (100%)

$9.67 (36.73%)

27

Hold

Since 13-Oct-2023

$15

$-14 (-48.28%)

$11

10 months 12 days ago
(27-Feb-2025)

3/5 (60%)

$2.2 (17.19%)

41

Show more analysts

Please expand the browser size to see the chart

What is ARQT (Arcutis Biotherapeutics ) average time for price targets to be met?

On average it took 98.87 days on average for the stock forecasts to be realized with a an average price target met ratio 39.15

Which analyst has the current highest performing score on ARQT (Arcutis Biotherapeutics ) with a proven track record?

GRAIG SUVANNAVEJH

Which analyst has the most public recommendations on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh works at MIZUHO and has 3 price targets and 1 ratings on ARQT

Which analyst is the currently most bullish on ARQT (Arcutis Biotherapeutics )?

Graig Suvannavejh with highest potential upside - $26

Which analyst is the currently most reserved on ARQT (Arcutis Biotherapeutics )?

Nigel Dally with lowest potential downside - -$19

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?